Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

EPIRUS Biopharmaceuticals Inc (OTC Pink - Limited Information:EPRSQ)

0.0061
Delayed Data
As of Sep 23
 -0.0009 / -12.86%
Today’s Change
0.01
Today|||52-Week Range
6.41
-99.80%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close0.01
Today’s open0.01
Day’s range0.01 - 0.01
Volume213,648
Average volume (3 months)2,118,201
Market cap$159.7K
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)+66.37%
Earnings growth (this year)+58.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+17,425.00%
P/E ratio--
Price/Sales100.27
Price/Book0.00

Competitors

No competitors data available.

Financials

Last reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$701.0K
Annual profit (last year)-$52.2M
Net profit margin-7,444.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Secretary, Senior Vice President &
General Counsel
Robert Ticktin
Vice President-Human Resources &
Administration
Jeff Kagy
Corporate headquarters
Boston, Massachusetts

Forecasts

Chart unavailable

Search for Jobs